Quest in broad deal with CDC for hepatitis analysis
January 27, 2015 at 14:59 PM EST
Jan 27 (Reuters) - Laboratory testing company Quest Diagnostics Inc said on Tuesday it had signed a $520,000 agreement with the Centers for Disease Control and Prevention to identify trends in screening, diagnosis and treatment of four strains of viral hepatitis.